Ozempic & GLP-1s Articles

How Long Do Ozempic Side Effects Last? A Patient’s Guide

Ozempic, a popular medication primarily prescribed to treat Type 2 diabetes, has gained significant attention in recent years due to its off-label use as a weight loss drug. Its effectiveness in regulating blood sugar and promoting weight loss has made it a go-to choice for many patients. However, Ozempic also comes with potential side effects—ranging from mild to severe—that can impact your quality of life.

Zepbound Lawsuit: What You Need To Know

Zepbound, a medication used to treat Type 2 diabetes and increasingly prescribed off-label for weight loss, has become the focus of a growing number of lawsuits. These lawsuits allege that Zepbound, like similar GLP-1 receptor agonists, can cause severe side effects that were not adequately disclosed by its manufacturer. As more patients come forward with claims of harm, it’s important to understand the details of the Zepbound lawsuits, the potential risks linked to this medication, and what this means for affected individuals.

Rybelsus Lawsuit: Overview and Updates

Rybelsus, a widely used medication for managing type 2 diabetes, has recently faced growing legal scrutiny due to severe side effects reported by patients. While Rybelsus is FDA-approved for diabetes management, some people are also taking it off-label for weight loss, sparking further concerns about its safety. As lawsuits emerge, patients and healthcare providers are seeking answers about the risks, legal claims, and updates on ongoing cases. This article provides a clear, up-to-date overview of the Rybelsus lawsuits and the reasons behind them.

The Largest Legal Payouts Against Major Companies

In recent years, mass tort litigation has played a crucial role in holding large companies accountable for harmful practices. A mass tort lawsuit allows multiple plaintiffs to sue a corporation over similar injuries or damages caused by the same product or action. These cases differ from class action lawsuits in that each plaintiff in a mass tort retains their own lawyer and individual damages. Here, we’ll explore some of the largest and most impactful mass tort cases involving major corporations, highlighting how these cases evolved and the consequences they have brought.

Mounjaro Interactions: Alcohol, Medications, and More

Mounjaro is a weekly injectable drug used to treat type 2 diabetes through improved blood sugar control. It’s part of the glucagon-like peptide-1 (GLP-1) receptor agonist family of medications that doctors recommend using alongside a healthy diet and exercise habits. It is produced by Eli Lilly and was originally approved for use in May 2022. While there have been extensive clinical trials to prove the safety of Mounjaro, this medication may have adverse reactions when taken with alcohol and other drugs.

Zepbound: Uses, Side Effects, and More

In November 2023, the Food and Drug Administration (FDA) approved Zepbound, a tirzepatide injection, for the American market. This medication is designed for “chronic weight management in adults with obesity” and has already been sold under the name Mounjaro for managing type 2 diabetes. Zepbound is produced by drug manufacturer Eli Lilly, which has struggled to keep up with demand for the drug. This medication competes with Novo Nordisk’s Wegovy, which is also approved as a weight loss drug.

Rybelsus Side Effects and Risk Factors

Rybelsus is the brand name for an oral semaglutide tablet. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it mimics the GLP-1 hormone that the body naturally releases in response to eating. GLP-1 slows the release of blood sugar and increases insulin production, making it beneficial for people with diabetes. Semaglutide also interacts with the part of the brain that controls appetite, lessening feelings of hunger in users.

Wevogy Lawsuit: What You Need To Know

In recent years, Wegovy has garnered significant attention as a prescription medication designed to help with weight loss. Initially approved in 2017 as a diabetes treatment under the name Ozempic, Wegovy was rebranded and approved for weight management in 2021. Its repurposing for weight loss was approved due to its remarkable efficacy in promoting weight reduction. It received additional FDA approval in March 2024 for lowering cardiovascular risks tied to obesity. 

What Are the Side Effects of Ozempic?

Ozempic is a semaglutide injection from the family of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. Patients inject this medication weekly, often into the soft tissue of the abdomen. Ozempic is prescribed to help patients with type 2 diabetes manage their blood sugar levels. However, it has also shown promising results in helping people lose weight. While Ozempic use has increased significantly in recent years — nearly 1.7% of Americans were prescribed a semaglutide medication in 2023 — some patients have experienced negative side effects from these injections.

Understanding the Mounjaro and Ozempic Lawsuits

Novo Nordisk and Eli Lilly, the manufacturers of Mounjaro and Ozempic, are currently facing dozens of lawsuits related to their products. The lawsuits are regarding the weekly injectable medications approved to help manage type 2 diabetes while also supporting weight loss. As of December 2023, there are more than 10,000 legal claims from patients and dozens of pending lawsuits. These drug manufacturers are facing legal action from patients who claimed they were not properly warned about the side effects of the medication — some of which were so severe the patients developed long-term conditions or were hospitalized.

GLP-1 Agonists: Drug Facts and Medication Side Effects

The past few years have seen a spike in prescriptions for Ozempic and Wegovy, two GLP-1 agonist injections that are used to treat type 2 diabetes. However, these medications aren’t necessarily being used by diabetics. They have become a popular choice for weight loss because they also work as appetite suppressants. One study found there were 1.9 billion claims from private insurers to cover GLP-1 medications in 2023 alone. In Kentucky, the state with the highest use of Ozempic and Wegovy, 21 patients were prescribed this medication for every 1,000 residents.

Ozempic For Weight Loss: What You Need To Know

Legally ReviewedThis article has been written and reviewed for legal accuracy and clarity by Tort Defenders’ writers and staff and is as accurate as possible. This content should not be taken as legal advice from an attorney. The use of Ozempic as a weight loss drug continues to soar in popularity in the United States. […]

Ozempic Lawsuit: Overview and Updates

Ozempic has been called the worst-kept secret in Hollywood as celebrities and influencers turn to this drug to lose weight. However, this isn’t just a medication for the rich and famous. People from all walks of life have started using Ozempic and similar injections to control their weight. Novo Nordisk, the maker of Ozempic and Wegovy, reached a market value of $506 billion in 2024 because of demand for its products.